- May 07, 2024Source: SurvivorNet
Do Patients Fare Better With Female Doctors? New Study Suggests They May — But Most Cancer Patients Rely on a Team, Not an Individual, for Care
- May 07, 2024
Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem Cell Transplantation
- May 07, 2024Source: JAMA Internal Medicine
Time for a Focus on Cessation of E-Cigarettes
- May 07, 2024Source: WWLP 22News (NBC)
New cancer study to focus on racial disparity survival rates
- May 07, 2024Source: VeryWell Health
Pancreatic Cancer Is Hard to Detect in Early Stages. A New Blood Test Could Help
- May 07, 2024Source: Urology Times
Dr. Braun and Dr. Kenney on unmet needs in kidney cancer
- May 06, 2024Source: Yale Medicine
Face Transplant: Yale Surgeon Finds His Work ‘Profound’
- May 06, 2024
Prasanna Ananth, MD, MPH, Named as an Emerging Leader in Hospice and Palliative Care 2024
Yale Cancer Center
Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 45 years, Yale Cancer Center is one of only 56 Centers in the nation. Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.
Yale Cancer Center is one of only 56 Comprehensive Cancer Centers in the country designated by the National Cancer Institute. The significance of this designation has profound implications for those who choose Yale as the place where they will be cared for and receive treatment for their cancer.
In the fight against cancer, Yale has been at the forefront of understanding the fundamental mechanisms of cancer biology and in developing effective therapies for cancer treatment.
Search Yale Cancer Center's Clinical Trials
Clinical trials are currently offered to our patients in all disease areas, including Phase I clinical trials for advanced and metastatic disease.
Upcoming Events
May 20248Today
Yale Only
Please contact MyelomaTumorBoard@ynhh.org for Zoom info.
May 20248Today
Yale Only Please contact BreastTumorBoard@ynhh.org for Zoom info.Everyone Sheila Lahijani, MD, FACLPZoom. Meeting ID: 933 0391 3582. Password: 921897